Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 21.85% | -106.14% | -80.01% | 54.20% | 58.29% |
| Total Depreciation and Amortization | -42.62% | -32.42% | -21.65% | -12.42% | -2.43% |
| Total Amortization of Deferred Charges | -19.86% | -22.18% | -20.07% | -16.39% | 12.93% |
| Total Other Non-Cash Items | -88.11% | -75.57% | -28.65% | -93.22% | -89.68% |
| Change in Net Operating Assets | -65.20% | 378.17% | 1,454.11% | 471.97% | 1,198.34% |
| Cash from Operations | -263.86% | 16.22% | 24.34% | 71.83% | 138.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | 88.60% | 100.00% |
| Cash from Investing | -- | -100.00% | -100.00% | 94.25% | 100.00% |
| Total Debt Issued | 1,400.00% | -28.29% | -19.18% | -34.77% | -95.72% |
| Total Debt Repaid | 63.17% | 59.94% | 40.22% | 3.76% | -71.19% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -100.00% | -4.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 207.07% | -7.87% | -24.29% | -66.96% | -154.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.75% | 84.29% | -375.00% | 277.46% | -390.73% |
